![clincloud](https://investor.igcpharma.com/wp-content/uploads/2024/04/PR-AD_03-min-1024x1024.jpg)
June 9, 2022
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
Facebook
Twitter
LinkedIn